The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET) Journal Articles Refereed uri icon

Overview

Published in

  • Cancer

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1002/cncr.30838

Additional Document Info

Parent Title

  • CANCER

Volume

  • 123

Issue

  • 18

Publisher

  • John Wiley & Sons